Tags

Type your tag names separated by a space and hit enter

[Lamellar keratoplasty in the management of recurrent pterygium].
Vestn Oftalmol. 2020; 136(5. Vyp. 2):214-218.VO

Abstract

As it is known, the main problem of surgical treatment of pterygium is associated with high risk of recurrence. Quite a number of surgical techniques now exist, all aimed at pterygium removal and only differing in the method of conjunctival closure following the excision. Due to relatively low recurrence rates, conjunctival or conjunctival-limbal autografts are currently the 'gold standard' of pterygium surgery. The frequency of recurrence is also insignificant in peripheral anterior lamellar keratoplasty, which is rarely performed due to its complexity and the need for donor cornea. However, it is considered to be the method of choice in cases of repeated recurrence as well as in patients with high pterygium activity. This article describes a clinical case of a massive recurrent pterygium (grade IV, activity level 3). The patient has had three previous surgeries (including conjunctival autotransplantation) that yielded no success. By performing large-diameter peripheral anterior lamellar keratoplasty in combination with adjuvant therapy (intraoperative mitomycin C and subconjunctival postoperative aflibercept injections), structural integrity of the cornea was finally restored without further recurrences and visual acuity was increased.

Authors+Show Affiliations

Research Institute of Eye Diseases, Moscow, Russia.

Pub Type(s)

Journal Article

Language

rus

PubMed ID

33063967

Citation

Trufanov, S V.. "[Lamellar Keratoplasty in the Management of Recurrent Pterygium]." Vestnik Oftalmologii, vol. 136, no. 5. Vyp. 2, 2020, pp. 214-218.
Trufanov SV. [Lamellar keratoplasty in the management of recurrent pterygium]. Vestn Oftalmol. 2020;136(5. Vyp. 2):214-218.
Trufanov, S. V. (2020). [Lamellar keratoplasty in the management of recurrent pterygium]. Vestnik Oftalmologii, 136(5. Vyp. 2), 214-218. https://doi.org/10.17116/oftalma2020136052214
Trufanov SV. [Lamellar Keratoplasty in the Management of Recurrent Pterygium]. Vestn Oftalmol. 2020;136(5. Vyp. 2):214-218. PubMed PMID: 33063967.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Lamellar keratoplasty in the management of recurrent pterygium]. A1 - Trufanov,S V, PY - 2020/10/16/entrez PY - 2020/10/17/pubmed PY - 2020/10/21/medline KW - adjuvant therapy KW - aflibercept KW - lamellar keratoplasty KW - mitomycin C KW - recurrent pterygium SP - 214 EP - 218 JF - Vestnik oftalmologii JO - Vestn Oftalmol VL - 136 IS - 5. Vyp. 2 N2 - As it is known, the main problem of surgical treatment of pterygium is associated with high risk of recurrence. Quite a number of surgical techniques now exist, all aimed at pterygium removal and only differing in the method of conjunctival closure following the excision. Due to relatively low recurrence rates, conjunctival or conjunctival-limbal autografts are currently the 'gold standard' of pterygium surgery. The frequency of recurrence is also insignificant in peripheral anterior lamellar keratoplasty, which is rarely performed due to its complexity and the need for donor cornea. However, it is considered to be the method of choice in cases of repeated recurrence as well as in patients with high pterygium activity. This article describes a clinical case of a massive recurrent pterygium (grade IV, activity level 3). The patient has had three previous surgeries (including conjunctival autotransplantation) that yielded no success. By performing large-diameter peripheral anterior lamellar keratoplasty in combination with adjuvant therapy (intraoperative mitomycin C and subconjunctival postoperative aflibercept injections), structural integrity of the cornea was finally restored without further recurrences and visual acuity was increased. SN - 0042-465X UR - https://www.unboundmedicine.com/medline/citation/33063967/[Lamellar_keratoplasty_in_the_management_of_recurrent_pterygium]_ L2 - https://medlineplus.gov/cornealdisorders.html DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.